CN113209230A - 一种甘麦大枣汤的制备方法 - Google Patents
一种甘麦大枣汤的制备方法 Download PDFInfo
- Publication number
- CN113209230A CN113209230A CN202110614637.XA CN202110614637A CN113209230A CN 113209230 A CN113209230 A CN 113209230A CN 202110614637 A CN202110614637 A CN 202110614637A CN 113209230 A CN113209230 A CN 113209230A
- Authority
- CN
- China
- Prior art keywords
- wheat
- liquorice
- enzymolysis
- enzyme
- soup
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 241000209140 Triticum Species 0.000 title claims abstract description 55
- 235000021307 Triticum Nutrition 0.000 title claims abstract description 55
- 235000014347 soups Nutrition 0.000 title claims abstract description 35
- 238000002360 preparation method Methods 0.000 title claims abstract description 18
- 235000009508 confectionery Nutrition 0.000 title description 17
- 240000008866 Ziziphus nummularia Species 0.000 title 1
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 claims abstract description 43
- 235000006545 Ziziphus mauritiana Nutrition 0.000 claims abstract description 41
- 244000126002 Ziziphus vulgaris Species 0.000 claims abstract description 41
- 235000008529 Ziziphus vulgaris Nutrition 0.000 claims abstract description 41
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 claims abstract description 40
- 244000303040 Glycyrrhiza glabra Species 0.000 claims abstract description 31
- 235000011477 liquorice Nutrition 0.000 claims abstract description 31
- 230000001954 sterilising effect Effects 0.000 claims abstract description 23
- 238000000034 method Methods 0.000 claims abstract description 18
- 239000000047 product Substances 0.000 claims abstract description 18
- 239000006228 supernatant Substances 0.000 claims abstract description 17
- 239000002994 raw material Substances 0.000 claims abstract description 5
- 235000011194 food seasoning agent Nutrition 0.000 claims abstract description 4
- 238000011049 filling Methods 0.000 claims abstract description 3
- 238000004806 packaging method and process Methods 0.000 claims abstract description 3
- 102000004190 Enzymes Human genes 0.000 claims description 37
- 108090000790 Enzymes Proteins 0.000 claims description 37
- 229940088598 enzyme Drugs 0.000 claims description 37
- 238000000605 extraction Methods 0.000 claims description 28
- 239000000706 filtrate Substances 0.000 claims description 22
- 241001247821 Ziziphus Species 0.000 claims description 19
- 238000004659 sterilization and disinfection Methods 0.000 claims description 17
- 235000003599 food sweetener Nutrition 0.000 claims description 15
- 239000003765 sweetening agent Substances 0.000 claims description 15
- 101710130006 Beta-glucanase Proteins 0.000 claims description 14
- 108010059892 Cellulase Proteins 0.000 claims description 14
- 108010059820 Polygalacturonase Proteins 0.000 claims description 14
- 102000004139 alpha-Amylases Human genes 0.000 claims description 14
- 108090000637 alpha-Amylases Proteins 0.000 claims description 14
- 229940024171 alpha-amylase Drugs 0.000 claims description 14
- 229940106157 cellulase Drugs 0.000 claims description 14
- 108010093305 exopolygalacturonase Proteins 0.000 claims description 14
- 238000001914 filtration Methods 0.000 claims description 13
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 13
- 238000005119 centrifugation Methods 0.000 claims description 11
- 241000202807 Glycyrrhiza Species 0.000 claims description 9
- 235000001453 Glycyrrhiza echinata Nutrition 0.000 claims description 9
- 235000017382 Glycyrrhiza lepidota Nutrition 0.000 claims description 9
- 229940010454 licorice Drugs 0.000 claims description 9
- 238000005303 weighing Methods 0.000 claims description 9
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 claims description 8
- 238000004140 cleaning Methods 0.000 claims description 8
- 238000012216 screening Methods 0.000 claims description 8
- 238000002791 soaking Methods 0.000 claims description 8
- 238000007873 sieving Methods 0.000 claims description 6
- 238000001816 cooling Methods 0.000 claims description 5
- 235000017557 sodium bicarbonate Nutrition 0.000 claims description 4
- 229910000030 sodium bicarbonate Inorganic materials 0.000 claims description 4
- 239000012535 impurity Substances 0.000 claims description 3
- 238000003756 stirring Methods 0.000 claims description 3
- SERLAGPUMNYUCK-DCUALPFSSA-N 1-O-alpha-D-glucopyranosyl-D-mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O SERLAGPUMNYUCK-DCUALPFSSA-N 0.000 claims description 2
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 claims description 2
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 claims description 2
- 239000004386 Erythritol Substances 0.000 claims description 2
- UNXHWFMMPAWVPI-UHFFFAOYSA-N Erythritol Natural products OCC(O)C(O)CO UNXHWFMMPAWVPI-UHFFFAOYSA-N 0.000 claims description 2
- UEDUENGHJMELGK-HYDKPPNVSA-N Stevioside Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O UEDUENGHJMELGK-HYDKPPNVSA-N 0.000 claims description 2
- 239000004376 Sucralose Substances 0.000 claims description 2
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 claims description 2
- 235000019414 erythritol Nutrition 0.000 claims description 2
- UNXHWFMMPAWVPI-ZXZARUISSA-N erythritol Chemical compound OC[C@H](O)[C@H](O)CO UNXHWFMMPAWVPI-ZXZARUISSA-N 0.000 claims description 2
- 229940009714 erythritol Drugs 0.000 claims description 2
- 239000000905 isomalt Substances 0.000 claims description 2
- 235000010439 isomalt Nutrition 0.000 claims description 2
- HPIGCVXMBGOWTF-UHFFFAOYSA-N isomaltol Natural products CC(=O)C=1OC=CC=1O HPIGCVXMBGOWTF-UHFFFAOYSA-N 0.000 claims description 2
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 claims description 2
- 229930189775 mogroside Natural products 0.000 claims description 2
- 239000000600 sorbitol Substances 0.000 claims description 2
- 235000010356 sorbitol Nutrition 0.000 claims description 2
- 229940013618 stevioside Drugs 0.000 claims description 2
- OHHNJQXIOPOJSC-UHFFFAOYSA-N stevioside Natural products CC1(CCCC2(C)C3(C)CCC4(CC3(CCC12C)CC4=C)OC5OC(CO)C(O)C(O)C5OC6OC(CO)C(O)C(O)C6O)C(=O)OC7OC(CO)C(O)C(O)C7O OHHNJQXIOPOJSC-UHFFFAOYSA-N 0.000 claims description 2
- 235000019202 steviosides Nutrition 0.000 claims description 2
- 235000019408 sucralose Nutrition 0.000 claims description 2
- BAQAVOSOZGMPRM-QBMZZYIRSA-N sucralose Chemical compound O[C@@H]1[C@@H](O)[C@@H](Cl)[C@@H](CO)O[C@@H]1O[C@@]1(CCl)[C@@H](O)[C@H](O)[C@@H](CCl)O1 BAQAVOSOZGMPRM-QBMZZYIRSA-N 0.000 claims description 2
- 239000000811 xylitol Substances 0.000 claims description 2
- 235000010447 xylitol Nutrition 0.000 claims description 2
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 claims description 2
- 229960002675 xylitol Drugs 0.000 claims description 2
- 230000000694 effects Effects 0.000 abstract description 9
- 238000005352 clarification Methods 0.000 abstract description 4
- 230000001953 sensory effect Effects 0.000 abstract description 4
- 239000002552 dosage form Substances 0.000 abstract description 2
- 235000013305 food Nutrition 0.000 abstract description 2
- 230000005906 menstruation Effects 0.000 abstract description 2
- 230000001105 regulatory effect Effects 0.000 abstract description 2
- 231100000252 nontoxic Toxicity 0.000 abstract 1
- 230000003000 nontoxic effect Effects 0.000 abstract 1
- 239000000243 solution Substances 0.000 description 32
- 238000012360 testing method Methods 0.000 description 17
- 241000699670 Mus sp. Species 0.000 description 14
- VTAJIXDZFCRWBR-UHFFFAOYSA-N Licoricesaponin B2 Natural products C1C(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2)C(O)=O)C)(C)CC2)(C)C2C(C)(C)CC1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O VTAJIXDZFCRWBR-UHFFFAOYSA-N 0.000 description 12
- LPLVUJXQOOQHMX-UHFFFAOYSA-N glycyrrhetinic acid glycoside Natural products C1CC(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2=O)C(O)=O)C)(C)CC2)(C)C2C(C)(C)C1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O LPLVUJXQOOQHMX-UHFFFAOYSA-N 0.000 description 12
- 229960004949 glycyrrhizic acid Drugs 0.000 description 12
- UYRUBYNTXSDKQT-UHFFFAOYSA-N glycyrrhizic acid Natural products CC1(C)C(CCC2(C)C1CCC3(C)C2C(=O)C=C4C5CC(C)(CCC5(C)CCC34C)C(=O)O)OC6OC(C(O)C(O)C6OC7OC(O)C(O)C(O)C7C(=O)O)C(=O)O UYRUBYNTXSDKQT-UHFFFAOYSA-N 0.000 description 12
- 239000001685 glycyrrhizic acid Substances 0.000 description 12
- 235000019410 glycyrrhizin Nutrition 0.000 description 12
- 239000012528 membrane Substances 0.000 description 9
- 241000699666 Mus <mouse, genus> Species 0.000 description 8
- 230000009182 swimming Effects 0.000 description 7
- RTHCYVBBDHJXIQ-MRXNPFEDSA-N (R)-fluoxetine Chemical compound O([C@H](CCNC)C=1C=CC=CC=1)C1=CC=C(C(F)(F)F)C=C1 RTHCYVBBDHJXIQ-MRXNPFEDSA-N 0.000 description 6
- 241001465754 Metazoa Species 0.000 description 6
- 238000001514 detection method Methods 0.000 description 6
- 230000003203 everyday effect Effects 0.000 description 6
- 239000012467 final product Substances 0.000 description 6
- 229960002464 fluoxetine Drugs 0.000 description 6
- 238000002156 mixing Methods 0.000 description 6
- 239000008213 purified water Substances 0.000 description 6
- 239000007788 liquid Substances 0.000 description 5
- 239000000725 suspension Substances 0.000 description 5
- 238000001471 micro-filtration Methods 0.000 description 4
- 239000002244 precipitate Substances 0.000 description 4
- 229920002472 Starch Polymers 0.000 description 3
- 230000000052 comparative effect Effects 0.000 description 3
- 238000007865 diluting Methods 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 239000013641 positive control Substances 0.000 description 3
- 235000019698 starch Nutrition 0.000 description 3
- 239000008107 starch Substances 0.000 description 3
- 241000196324 Embryophyta Species 0.000 description 2
- 208000004356 Hysteria Diseases 0.000 description 2
- GIYXAJPCNFJEHY-UHFFFAOYSA-N N-methyl-3-phenyl-3-[4-(trifluoromethyl)phenoxy]-1-propanamine hydrochloride (1:1) Chemical compound Cl.C=1C=CC=CC=1C(CCNC)OC1=CC=C(C(F)(F)F)C=C1 GIYXAJPCNFJEHY-UHFFFAOYSA-N 0.000 description 2
- 208000007443 Neurasthenia Diseases 0.000 description 2
- 206010003549 asthenia Diseases 0.000 description 2
- 210000002421 cell wall Anatomy 0.000 description 2
- 208000012839 conversion disease Diseases 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 239000003651 drinking water Substances 0.000 description 2
- 235000020188 drinking water Nutrition 0.000 description 2
- 229960000389 fluoxetine hydrochloride Drugs 0.000 description 2
- 238000005286 illumination Methods 0.000 description 2
- 239000002504 physiological saline solution Substances 0.000 description 2
- 208000011580 syndromic disease Diseases 0.000 description 2
- 230000002936 tranquilizing effect Effects 0.000 description 2
- 206010000117 Abnormal behaviour Diseases 0.000 description 1
- 208000019901 Anxiety disease Diseases 0.000 description 1
- 229920001353 Dextrin Polymers 0.000 description 1
- 239000004375 Dextrin Substances 0.000 description 1
- 238000012449 Kunming mouse Methods 0.000 description 1
- 241001282135 Poromitra oscitans Species 0.000 description 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
- UIIMBOGNXHQVGW-DEQYMQKBSA-M Sodium bicarbonate-14C Chemical compound [Na+].O[14C]([O-])=O UIIMBOGNXHQVGW-DEQYMQKBSA-M 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical group [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 206010048232 Yawning Diseases 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 230000036506 anxiety Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 235000013361 beverage Nutrition 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 235000019425 dextrin Nutrition 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 238000003304 gavage Methods 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 206010022437 insomnia Diseases 0.000 description 1
- 230000002045 lasting effect Effects 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 238000005374 membrane filtration Methods 0.000 description 1
- 230000003340 mental effect Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 231100000956 nontoxicity Toxicity 0.000 description 1
- 229920001542 oligosaccharide Polymers 0.000 description 1
- 150000002482 oligosaccharides Chemical class 0.000 description 1
- 230000000750 progressive effect Effects 0.000 description 1
- 230000029219 regulation of pH Effects 0.000 description 1
- 230000033764 rhythmic process Effects 0.000 description 1
- 239000008354 sodium chloride injection Substances 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 150000005846 sugar alcohols Chemical class 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 239000013076 target substance Substances 0.000 description 1
- 239000012085 test solution Substances 0.000 description 1
- 229940125725 tranquilizer Drugs 0.000 description 1
- 239000003204 tranquilizing agent Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/899—Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L23/00—Soups; Sauces; Preparation or treatment thereof
- A23L23/10—Soup concentrates, e.g. powders or cakes
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L27/00—Spices; Flavouring agents or condiments; Artificial sweetening agents; Table salts; Dietetic salt substitutes; Preparation or treatment thereof
- A23L27/30—Artificial sweetening agents
- A23L27/33—Artificial sweetening agents containing sugars or derivatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L27/00—Spices; Flavouring agents or condiments; Artificial sweetening agents; Table salts; Dietetic salt substitutes; Preparation or treatment thereof
- A23L27/30—Artificial sweetening agents
- A23L27/33—Artificial sweetening agents containing sugars or derivatives
- A23L27/34—Sugar alcohols
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L27/00—Spices; Flavouring agents or condiments; Artificial sweetening agents; Table salts; Dietetic salt substitutes; Preparation or treatment thereof
- A23L27/30—Artificial sweetening agents
- A23L27/33—Artificial sweetening agents containing sugars or derivatives
- A23L27/37—Halogenated sugars
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
- A23L29/06—Enzymes
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/125—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives containing carbohydrate syrups; containing sugars; containing sugar alcohols; containing starch hydrolysates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/484—Glycyrrhiza (licorice)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/72—Rhamnaceae (Buckthorn family), e.g. buckthorn, chewstick or umbrella-tree
- A61K36/725—Ziziphus, e.g. jujube
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/10—Preparation or pretreatment of starting material
- A61K2236/19—Preparation or pretreatment of starting material involving fermentation using yeast, bacteria or both; enzymatic treatment
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation, decoction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/39—Complex extraction schemes, e.g. fractionation or repeated extraction steps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/51—Concentration or drying of the extract, e.g. Lyophilisation, freeze-drying or spray-drying
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/53—Liquid-solid separation, e.g. centrifugation, sedimentation or crystallization
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Nutrition Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Mycology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Microbiology (AREA)
- Botany (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medical Informatics (AREA)
- Alternative & Traditional Medicine (AREA)
- Biotechnology (AREA)
- Molecular Biology (AREA)
- Pain & Pain Management (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Biochemistry (AREA)
- Psychiatry (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Anesthesiology (AREA)
- Medicines Containing Plant Substances (AREA)
- Seasonings (AREA)
Abstract
本发明公开了一种甘麦大枣汤的制备方法,属于食品制备技术领域,具体包括以下步骤:(1)原料预处理;(2)提取;(3)酶解;(4)浓缩离心;(5)调节pH后静置离心,收集上清液三;(6)调味定容后灌装、灭菌、包装,得到所述甘麦大枣汤。本发明按经方配方、工艺及剂型,很好的保留其疗效,用酶解的方式解决本产品的澄清问题,保留煎煮液中的有效成分,提高产品的稳定性及品质,使消费者具有较好的感官体验。同时本产品口味良好,饮用方便,无依赖性,无毒性,便于携带、储存、运输,促进了该经典配方的推广。
Description
技术领域
本发明涉及食品制备技术领域,更具体的说是涉及一种甘麦大枣汤的制备方法。
背景技术
甘麦大枣汤,中医方剂名。为安神剂,具有养心安神,和中缓急之功效。主治脏躁。症见精神恍惚,常悲伤欲哭,不能自主,心中烦乱,睡眠不安,甚则言行失常,呵欠频作,舌淡红苔少,脉细微数。临床常用于治疗癔病、更年期综合征、神经衰弱、小儿夜啼等属心阴不足,肝气失和者。
现有技术中,中药饮料贮存期间较易发生浑浊,产生沉淀,传统的离心,过滤方法往往很难获得较为理想的澄清效果,同时也会导致许多有效成分的流失。且产品形式是传统普通的药品形式,并不能十分的吸引消费者的眼光。
因此,如何提供一种澄清度高且稳定性高的甘麦大枣汤是本领域技术人员亟需解决的问题。
发明内容
有鉴于此,本发明提供了一种澄清透亮、稳定性高且适用人群广的甘麦大枣汤。
为了实现上述目的,本发明采用如下技术方案:
一种甘麦大枣汤的制备方法,包括以下步骤:
(1)原料预处理:将小麦、甘草和大枣筛选除去杂质后称重,然后洗净备用;
(2)提取:将预处理后的小麦、甘草和大枣加8倍水浸泡0.5-1h后煎煮0.5-1h,然后经80-200目筛过滤,得到滤液,再向滤渣中加6倍水再次煎煮0.5-1h后经80-200目筛过滤,合并两次滤液,得到提取液;
(3)酶解:向所述提取液中加入酶搅拌均匀,然后进行酶解,再将酶解产物进行离心,收集上清液一;
(4)浓缩:将所述上清液一减压浓缩至所述甘麦大枣汤体积的80%,自然冷却至室温,再冷藏静置24h后离心,得到上清液二;
(5)向所述上清液二中滴加碳酸氢钠调节pH至7-7.5,静置离心,收集上清液三;
(6)向所述上清液三中加入甜味剂调味,并定容,然后进行灌装、灭菌、包装,得到所述甘麦大枣汤。
有益效果:本发明能够显著提高植物细胞壁破坏率,使提取目的物得到更充分的释放,明显提高提取得率,耐高温α-淀粉酶在较高的温度下迅速水解淀粉分子中α-1.4葡萄糖苷键,任意切断成长短不一的短链糊精和少量的低聚糖,从而使淀粉的粘度迅速下降。离心后沉淀较不酶解样品少,经酸度调节剂调节pH后,上清液三分装灭菌后几乎无沉淀析出。并且,本发明能够最大程度的保留甘草酸,不会降低甘草酸含量。
优选的,所述小麦、甘草、大枣、酶和甜味剂的重量比为(15-30):(2-10):(2-15):(0.5-1.0):(0.5-5)。
优选的,所述小麦、甘草、大枣、酶和甜味剂的重量比为(22-30):(6-10):(4-10):(0.5-1.0):(1-3)。
优选的,所述小麦、甘草、大枣、酶和甜味剂的重量比为30:9:6:0.7:2。
优选的,步骤(2)中所述合并滤液后还包括一次浓缩:将合并后的滤液减压浓缩至61℃下相对密度为1.038±0.005的浓缩滤液,冷却至室温。
优选的,步骤(3)中所述酶为提取酶和耐高温α-淀粉酶质量比为1:1的混合酶;
所述提取酶为纤维素酶、果胶酶和β-葡聚糖酶的混合酶,且所述纤维素酶、果胶酶和β-葡聚糖酶的质量比为40:30:9。
优选的,步骤(3)中所述酶解温度为50℃,酶解时间为2-5h;
或,
所述酶解温度为室温,酶解时间为12-24h。
有益效果:本发明采用酶解工艺,解决了产品的澄清问题,改善了产品的稳定性及品质,提高了原料的提取得率,优化了原料提取液的口感,赋予消费者良好的感官体验。并且,本发明在制备过程中没有进行微滤膜过滤,大大降低了甘草酸在过滤过程中的损失。
优选的,步骤(6)中所述甜味剂包括三氯蔗糖、甜菊糖苷、罗汉果甜苷、木糖醇、山梨糖醇、异麦芽酮糖醇和赤藓糖醇中的一种或几种。
有益效果:本发明使用高倍甜味剂或糖醇调味,照顾到患糖尿病、龋齿等人群,增大适宜人群范围。
优选的,步骤(4)中所述减压浓缩温度为65-80℃,真空度为0.08-0.09MPa。
有益效果:本发明中的减压浓缩可在较低温度下,较快的实现提取液的浓缩,减少有效成分的损失;
优选的,步骤(5)中所述静置时间为3-6h;所述静置离心后还包括过筛,且所述过筛为过100-300目筛。
有益效果:上述过筛能够防止离心不彻底。
优选的,步骤(3)-(5)中所述离心速度为4000r/min;离心时间为30min。
有益效果:上述离心过程中的工艺参数限定能够保证离心彻底。
优选的,步骤(5)中所述灭菌为高压灭菌;且所述灭菌温度为105℃,灭菌时间为30min,灭菌压力为0.1MPa。
经由上述的技术方案可知,与现有技术相比,本发明公开提供了一种甘麦大枣汤及其制备方法,具有以下有益效果:
(1)本发明按经方配方、工艺及剂型,很好的保留其疗效,缓解因工作、生活节奏加快而导致的精神焦虑、紧张以及神经衰弱、失眠等,临床上常用于妇女更年期综合征的治疗;
(2)本发明用酶解的方式解决本产品的澄清问题,在传统工艺的基础上,显著提高植物细胞壁破坏率,使提取目的物得到更充分的释放,明显提高提取得率,使淀粉提前在体外分解,保留煎煮液中的有效成分,提高产品的稳定性及品质,使消费者具有较好的感官体验;
(3)本产品口味良好,饮用方便,无依赖性,无毒性,便于携带、储存、运输,促进了该经典配方的推广。
具体实施方式
下面将结合本发明实施例中的技术方案进行清楚、完整地描述,显然,所描述的实施例仅仅是本发明一部分实施例,而不是全部的实施例。基于本发明中的实施例,本领域普通技术人员在没有做出创造性劳动前提下所获得的所有其他实施例,都属于本发明保护的范围。
实施例1
一种甘麦大枣汤的制备方法,包括以下步骤:
(1)称取小麦:300g,甘草:90g,大枣:60g,提取酶:5g,耐高温α-淀粉酶:5g,碳酸氢钠:4g,备用。
其中,提取酶为纤维素酶、果胶酶和β-葡聚糖酶的混合酶,且纤维素酶、果胶酶和β-葡聚糖酶的质量比为40:30:9。
(2)提取:将小麦、甘草、大枣筛选,洗净后加入提取罐中,用纯净水浸泡1次后,煎煮0.5-1h,收集80-200目过滤的滤液,然后重复煎煮1-2次,合并滤液为提取液。
(3)酶解:向提取液中按相应配方量分别加入提取酶和耐高温α-淀粉酶,室温酶解12-24h;
(4)浓缩:按投料量浓缩至最终甘麦大枣汤产品体积的80%,冷藏24h以上,然后在4000r/min转速下离心30min,收集上清液。
(5)调节pH:碳酸氢钠配制成5%碳酸氢钠溶液,并加入到上清液中调pH,充分搅拌后静置4h,然后以4000r/min离心30min,再过100-300目筛网,最后添加甜味剂调配、定容。
(6)进一步的将产品进行灌装后高压灭菌,且灭菌温度为105℃,灭菌时间为30min,灭菌压力为0.1MPa,然后进行包装,得到甘麦大枣汤。
经检测,上述甘麦大枣汤中的甘草酸含量为1.42mg/mL。
实施例2
一种甘麦大枣汤的制备方法,包括以下步骤:
(1)按质量份称,小麦:300g,甘草:90g,大枣:60g,提取酶:5g,耐高温α-淀粉酶:5g,备用。
其中,提取酶为纤维素酶、果胶酶和β-葡聚糖酶的混合酶,且纤维素酶、果胶酶和β-葡聚糖酶的质量比为40:30:9。
(2)提取:将小麦、甘草、大枣筛选,洗净后加入至提取罐中,用纯净水浸泡1次后,煎煮0.5-1h,收集80-200目过滤的滤液,然后重复煎煮1-2次,合并滤液为提取液,备用。
(3)浓缩:将提取液减压浓缩至相对密度为1.038±0.005(61℃)的浓缩液,冷却至室温,备用。
(4)酶解:向浓缩液中分别加入提取酶和耐高温α-淀粉酶,50℃酶解2-5h,然后将酶解液在4000r/min的离心速度下离心30min;
(5)二次浓缩:按投料量浓缩至最终甘麦大枣汤产品的80%,冷藏48h后,在4000r/min的离心速度下离心30min,然后加入甜味剂调配、定容。
(6)进一步的将产品进行灌装后高压灭菌,且灭菌温度为105℃,灭菌时间为30min,灭菌压力为0.1MPa,然后进行包装,得到甘麦大枣汤。。
经检测,上述甘麦大枣汤中的甘草酸含量为1.67mg/mL。
实施例3
一种甘麦大枣汤的制备方法,包括以下步骤:
(1)按质量份称,小麦:300g,甘草:90g,大枣:60g,提取酶:5g,耐高温α-淀粉酶:5g。
其中,提取酶为纤维素酶、果胶酶和β-葡聚糖酶的混合酶,且纤维素酶、果胶酶和β-葡聚糖酶的质量比为40:30:9。
(2)提取:将小麦、甘草、大枣筛选,洗净后加入至提取罐中,用纯净水浸泡1次,煎煮0.5-1h,收集80-200目过滤的滤液,然后重复煎煮1-2次,合并滤液为提取液,备用。
(3)酶解:向提取液中分别加入提取酶和耐高温α-淀粉酶,50℃酶解2-5h,或者室温酶解12-24h,然后将酶解液在4000r/min离心速度下离心30min。
(4)浓缩:将离心液减压浓缩按投料量浓缩至最终甘麦大枣汤产品的80%,冷藏48h以上,然后将浓缩液在4000r/min离心速度下离心30min,再加入甜味剂调配、定容。
(5)进一步的将产品进行灌装后高压灭菌,且灭菌温度为105℃,灭菌时间为30min,灭菌压力为0.1MPa,然后进行包装,得到甘麦大枣汤。
经检测,上述甘麦大枣汤中的甘草酸含量为1.55mg/mL。
实施例4
一种甘麦大枣汤的制备方法,与实施例1不同的是:
步骤(1)中按质量份称,小麦:300g,甘草:90g,大枣:60g,提取酶:6g,耐高温α-淀粉酶:6g。
对比例1
一种甘麦大枣汤的制备方法,包括以下步骤:
(1)按质量份称,小麦:300g,甘草:90g,大枣:60g。
(2)提取:将小麦、甘草、大枣筛选,洗净后加入至提取罐中,用纯净水浸泡1次,煎煮0.5-1h,收集80-200目过滤的滤液,然后重复煎煮1-2次,合并滤液为提取液,备用。
(3)浓缩、冷藏、离心:将提取液减压浓缩,按投料量浓缩至最终甘麦大枣汤产品的80%,冷藏48h以上,然后将浓缩液在4000r/min离心速度下离心30min,再加入甜味剂调配,得调配液,备用。
(4)微滤膜过滤:调配液经5μm滤膜过滤,而后定容,灌装,105℃灭菌30min,得到甘麦大枣汤。
经检测,上述甘麦大枣汤中的甘草酸含量为1.38mg/mL。
对比例2
一种甘麦大枣汤的制备方法,包括以下步骤:
(1)按质量份称,小麦:300g,甘草:90g,大枣:60g,提取酶:5g,耐高温α-淀粉酶:5g。
其中,提取酶为纤维素酶、果胶酶和β-葡聚糖酶的混合酶,且纤维素酶、果胶酶和β-葡聚糖酶的质量比为40:30:9。
(2)提取:将小麦、甘草、大枣筛选,洗净后加入至提取罐中,用纯净水浸泡1次,煎煮0.5-1h,收集80-200目过滤的滤液,然后重复煎煮1-2次,合并滤液为提取液,备用。
(3)酶解:向提取液中分别加入提取酶和耐高温α-淀粉酶,50℃酶解2-5h,或者室温酶解12-24h,然后将酶解液在4000r/min离心速度下离心30min。
(4)浓缩、冷藏、离心:将酶解液减压浓缩按投料量浓缩至最终甘麦大枣汤产品的80%,冷藏48h以上,然后将浓缩液在4000r/min离心速度下离心30min,再加入甜味剂调配,得调配液,备用。
(5)微滤膜过滤:调配液经5μm滤膜过滤,而后定容,灌装,105℃灭菌30min。
经检测,上述甘麦大枣汤中的甘草酸含量为1.31mg/mL;
对比例3
一种甘麦大枣汤的制备方法,包括以下步骤:
(1)按质量份称,小麦:300g,甘草:90g,大枣:60g,提取酶:5g,耐高温α-淀粉酶:5g。
其中,提取酶为纤维素酶、果胶酶和β-葡聚糖酶的混合酶,且纤维素酶、果胶酶和β-葡聚糖酶的质量比为40:30:9。
(2)提取:将小麦、甘草、大枣筛选,洗净后加入至提取罐中,用纯净水浸泡1次,煎煮0.5-1h,收集80-200目过滤的滤液,然后重复煎煮1-2次,合并滤液为提取液,备用。
(3)酶解:向提取液中分别加入提取酶和耐高温α-淀粉酶,50℃酶解2-5h,或者室温酶解12-24h,然后将酶解液在4000r/min离心速度下离心30min。
(4)浓缩、冷藏、离心:将酶解液减压浓缩按投料量浓缩至最终甘麦大枣汤产品的80%,冷藏48h以上,然后将浓缩液在4000r/min离心速度下离心30min,再加入甜味剂调配,得调配液,备用。
(5)微滤膜过滤:调配液经3μm滤膜过滤,而后定容,灌装,105℃灭菌30min。
经检测,上述甘麦大枣汤中的甘草酸含量为0.92mg/mL。
以上数据表明,是否过滤以及滤膜孔径大小均对甘草酸含量有一定的影响,而对于仅离心过滤膜和酶解后过滤膜两种工艺,所得样品甘草酸含量相近,说明酶解对甘草酸含量影响较小。
技术效果:
采用本发明实施例1-4的方法制得的一种甘麦大枣汤,经试验检测,结果如下:
感官指标:棕色澄清透明液体,无沉淀、无杂质、略有甘草的甘甜。
功效试验
1.试验目的:检验产品是否具有抗抑郁作用。
2.试验材料:样品:甘麦大枣饮,棕色液体,密封,置阴凉、通风、干燥处保存。甘麦大枣饮(酶解前):除酶解、调pH相关步骤其余工艺同前,记为传统汤剂。
3.试验动物:SPF级KM种小鼠,体重16-20g。
4.试验环境条件:清洁恒温环境,饲养环境平均温度为:25℃,平均湿度为:37%。15-20次/小时全新风。光照:自然光照。
5.试验仪器及相关试液:盐酸氟西汀胶囊(20mg/片)由奥麦伦(Omelam)药厂出品,用0.9%氯化钠注射液配制成所需浓度;
6.样品处理:设口服液低、中、高剂量分别为6.67mL/kg、13.33mL/kg、40mL/kg(分别相当于人体推荐剂量的5、10、30倍)。
7.实验方法
7.1.小鼠悬挂试验
取小鼠,随机分6组,生理盐水组(空白对照组),氟西汀对照组(阳性对照组)、传统汤剂组,甘麦大枣饮高、中、低剂量各一组,每组10只。空白对照组每天灌胃给予生理盐水0.2mL/10g,氟西汀阳性对照组每天按0.33mg/kg灌胃给予氟西汀溶液,传统汤剂组每天按13.33mL/kg灌胃给予传统汤剂,其余各组按高中低剂量的药量给药,设口服液低、中、高剂量分别为6.67mL/kg、13.33mL/kg、40mL/kg(分别相当于人体推荐剂量的5、10、30倍),1次/天,连续21天,试验期间动物自由摄食饮水。末次给药30min后,固定小鼠尾端,使其倒挂,头离地约5cm,以挡板隔离动物视线,动物为克服不正常体位而挣扎活动,但活动一段时间后出现间断性不动,显示失望状态。记录6min内小鼠不动时间为失望时间(记录时间时应以持续3s以上不动为有效不动时间)。
表14组小鼠悬尾不动时间比较
注:与空白组比较:*P<0.05,**P<0.01
从表1得知,甘麦大枣饮高、中剂量和盐酸氟西汀,与空白组比较,均能显著缩短悬尾不动时间(P<0.01),与传统汤剂组比较,悬尾不动时间减少,而甘麦大枣饮低剂量对小鼠悬尾不动时间无显著影响。
7.2小鼠强迫游泳试验
预试将雌性小鼠单个放入水深为15cm左右的烧杯中(高30cm,直径20cm),水温25℃,水深可稍作调整,以小鼠后足刚可触及烧杯底又不足以支撑身体为宜。初放入时,小鼠强迫游泳并挣扎向上爬或潜入烧杯底,2~3min后活动逐渐减弱,出现间歇性不动状态,且时间越来长,5~6min后不动状态的时间占总时间的80%左右,预试15min以后将小鼠用干毛巾擦干。实验分组剔除预试中的不合格者,将合格的小鼠随机分成6组,每组10只,空白对照组每天灌胃给予生理盐水0.2mL/10g,氟西汀阳性对照组每天按0.33mg/kg灌胃给予氟西汀溶液,传统汤剂每天灌胃给予传统汤剂13.33mL/kg,其余各组按高中低剂量的药量给药,设口服液低、中、高剂量分别为6.67mL/kg、13.33mL/kg、40mL/kg(分别相当于人体推荐剂量的5、10、30倍),1次/天,连续21天,试验期间动物自由摄食饮水。末次灌胃给药后30min,在与预试条件完全相同的情况下,把小鼠放入烧杯中,记录5min内小鼠强迫游泳的不动时间。
表24组小鼠游泳不动时间比较
注:与空白组比较:*P<0.05,**P<0.01
从表2得知,甘麦大枣饮低剂量组对小鼠游泳不动时间无显著影响,中剂量组的小鼠游泳不动时间显著低于空白组(P<0.05),高剂量组与氟西汀组的小鼠游泳不动时间极显著低于空白组(P<0.01),中、高剂量组与传统剂量组比较,小鼠游泳不动时间减少。
两种试验结果显示:除甘麦大枣饮低剂量组,甘麦大枣饮高、中2种剂量均有抗抑郁活性,两剂量组与空白对照组比较,差异显著,高剂量最优,中剂量次之,高、中剂量组与传统剂量组比较,抗抑郁效果有所提升。
本说明书中各个实施例采用递进的方式描述,每个实施例重点说明的都是与其他实施例的不同之处,各个实施例之间相同相似部分互相参见即可。
对所公开的实施例的上述说明,使本领域专业技术人员能够实现或使用本发明。对这些实施例的多种修改对本领域的专业技术人员来说将是显而易见的,本文中所定义的一般原理可以在不脱离本发明的精神或范围的情况下,在其它实施例中实现。因此,本发明将不会被限制于本文所示的这些实施例,而是要符合与本文所公开的原理和新颖特点相一致的最宽的范围。
Claims (10)
1.一种甘麦大枣汤的制备方法,其特征在于,包括以下步骤:
(1)原料预处理:将小麦、甘草和大枣筛选除去杂质后称重,然后洗净备用;
(2)提取:将预处理后的小麦、甘草和大枣加8倍水浸泡0.5-1h后煎煮0.5-1h,然后经80-200目筛过滤,得到滤液,再向滤渣中加6倍水再次煎煮0.5-1h后经80-200目筛过滤,合并两次滤液,得到提取液;
(3)酶解:向所述提取液中加入酶搅拌均匀,然后进行酶解,再将酶解产物进行离心,收集上清液一;
(4)浓缩:将所述上清液一减压浓缩至所述甘麦大枣汤体积的80%,自然冷却至室温,再冷藏静置24h后离心,得到上清液二;
(5)向所述上清液二中滴加碳酸氢钠调节pH至7-7.5,静置离心,收集上清液三;
(6)向所述上清液三中加入甜味剂调味,并定容,然后进行灌装、灭菌、包装,得到所述甘麦大枣汤。
2.根据权利要求1所述的一种甘麦大枣汤的制备方法,其特征在于,所述小麦、甘草、大枣、酶和甜味剂的重量比为(15-30):(2-10):(2-15):(0.5-1.0):(0.5-5)。
3.根据权利要求2所述的一种甘麦大枣汤的制备方法,其特征在于,步骤(2)中所述合并滤液后还包括一次浓缩:将合并后的滤液减压浓缩至61℃下相对密度为1.038±0.005的浓缩滤液,冷却至室温。
4.根据权利要求2所述的一种甘麦大枣汤的制备方法,其特征在于,步骤(3)中所述酶为提取酶和耐高温α-淀粉酶质量比为1:1的混合酶;
所述提取酶为纤维素酶、果胶酶和β-葡聚糖酶的混合酶,且所述纤维素酶、果胶酶和β-葡聚糖酶的质量比为40:30:9。
5.根据权利要求3所述的一种甘麦大枣汤的制备方法,其特征在于,步骤(3)中所述酶解温度为50℃,酶解时间为2-5h;
或,
所述酶解温度为室温,酶解时间为12-24h。
6.根据权利要求2所述的一种甘麦大枣汤的制备方法,其特征在于,步骤(6)中所述甜味剂包括三氯蔗糖、甜菊糖苷、罗汉果甜苷、木糖醇、山梨糖醇、异麦芽酮糖醇和赤藓糖醇中的一种或几种。
7.根据权利要求1所述的一种甘麦大枣汤的制备方法,其特征在于,步骤(4)中所述减压浓缩温度为65-80℃,真空度为0.08-0.09MPa。
8.根据权利要求1所述的一种甘麦大枣汤的制备方法,其特征在于,步骤(5)中所述静置时间为3-6h;所述静置离心后还包括过筛,且所述过筛为过100-300目筛。
9.根据权利要求1-8任一所述的一种甘麦大枣汤的制备方法,其特征在于,步骤(3)-(5)中所述离心速度为4000r/min;离心时间为30min。
10.根据权利要求1所述的一种甘麦大枣汤的制备方法,其特征在于,步骤(5)中所述灭菌为高压灭菌;且所述灭菌温度为105℃,灭菌时间为30min,灭菌压力为0.1Mpa。
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202211254358.8A CN115645496A (zh) | 2021-06-02 | 2021-06-02 | 一种甘麦大枣汤的制备方法 |
CN202110614637.XA CN113209230A (zh) | 2021-06-02 | 2021-06-02 | 一种甘麦大枣汤的制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202110614637.XA CN113209230A (zh) | 2021-06-02 | 2021-06-02 | 一种甘麦大枣汤的制备方法 |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202211254358.8A Division CN115645496A (zh) | 2021-06-02 | 2021-06-02 | 一种甘麦大枣汤的制备方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN113209230A true CN113209230A (zh) | 2021-08-06 |
Family
ID=77082371
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202110614637.XA Pending CN113209230A (zh) | 2021-06-02 | 2021-06-02 | 一种甘麦大枣汤的制备方法 |
CN202211254358.8A Pending CN115645496A (zh) | 2021-06-02 | 2021-06-02 | 一种甘麦大枣汤的制备方法 |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202211254358.8A Pending CN115645496A (zh) | 2021-06-02 | 2021-06-02 | 一种甘麦大枣汤的制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (2) | CN113209230A (zh) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN114146144A (zh) * | 2021-11-03 | 2022-03-08 | 普洱市民族传统医药研究所 | 一种甘麦大枣汤制备工艺及生产设备 |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102911924A (zh) * | 2012-10-29 | 2013-02-06 | 华南理工大学 | 一种制糖工业用复合酶澄清剂及其制备方法和应用 |
CN103271157A (zh) * | 2013-05-23 | 2013-09-04 | 宁夏夏进乳业集团股份有限公司 | 一种谷物养生奶及其制备方法 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104225295B (zh) * | 2014-08-21 | 2017-02-08 | 北华大学 | 用于改善睡眠的组合物及其制备方法和应用 |
CN104800633A (zh) * | 2015-04-24 | 2015-07-29 | 天津中医药大学 | 一种甘麦大枣汤制剂、其制备方法及用途 |
CN110433253A (zh) * | 2018-05-03 | 2019-11-12 | 杭州市妇产科医院 | 一种甘麦大枣颗粒及其制备方法和应用 |
-
2021
- 2021-06-02 CN CN202110614637.XA patent/CN113209230A/zh active Pending
- 2021-06-02 CN CN202211254358.8A patent/CN115645496A/zh active Pending
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102911924A (zh) * | 2012-10-29 | 2013-02-06 | 华南理工大学 | 一种制糖工业用复合酶澄清剂及其制备方法和应用 |
CN103271157A (zh) * | 2013-05-23 | 2013-09-04 | 宁夏夏进乳业集团股份有限公司 | 一种谷物养生奶及其制备方法 |
Non-Patent Citations (1)
Title |
---|
郑劼,等: "甘麦大枣汤联合氟西汀通过调控肠道菌群改善慢性应激小鼠抑郁症状的研究", 《南京中医药大学学报》 * |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN114146144A (zh) * | 2021-11-03 | 2022-03-08 | 普洱市民族传统医药研究所 | 一种甘麦大枣汤制备工艺及生产设备 |
Also Published As
Publication number | Publication date |
---|---|
CN115645496A (zh) | 2023-01-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101518353A (zh) | 一种解酒败火护肝饮料及制备方法 | |
CN107557224B (zh) | 一种拐枣枸杞保健酒及其的酿造方法 | |
CN110012990A (zh) | 一种多功能保健饮品及其制备方法 | |
CN107083311A (zh) | 壳寡糖健康养生酒及其制备方法 | |
KR20150040392A (ko) | 스테비아 음료원액제조방법 | |
CN101828738B (zh) | 防治糖尿病的保健饮料 | |
CN102894435B (zh) | 一种缓解视疲劳的桑杞保健液 | |
CN113209230A (zh) | 一种甘麦大枣汤的制备方法 | |
CN101955874B (zh) | 一种苦杏酒的酿造方法 | |
CN104222287A (zh) | 一种能抗疲劳防衰老的保健牛奶及其制备方法 | |
CN116531444A (zh) | 镇咳清肺软胶囊及其制备工艺 | |
CN110710626A (zh) | 银耳燕窝复合悬浮饮料及其制备方法 | |
CN110710625A (zh) | 银耳复合悬浮饮料及其制备方法 | |
CN115104730A (zh) | 一种改善睡眠的组合物、线叶金雀花-芦笋睡眠改善液、茶粉的制备方法和应用 | |
CN104207286A (zh) | 一种护肝中草药保健醋饮料 | |
CN108125082A (zh) | 一种止咳润肺饮料 | |
CN113812591A (zh) | 一种安神助眠百合蜜片保健果冻及其制备方法 | |
CN103859520B (zh) | 有助于改善睡眠功能的刺五加果口服液及制备方法 | |
KR101982129B1 (ko) | 숙취해소음료 및 그 제조방법 | |
CN111685245A (zh) | 一种能够有效缓解酒后身体不适的软饮料及其制作方法 | |
CN105380267B (zh) | 一种功能食品及其制备方法 | |
CN109077207A (zh) | 一种沙棘南瓜复合果汁配方及其加工工艺 | |
CN110801015A (zh) | 健脑安神和增强记忆作用的核桃紫苏鱼油胶囊及制备方法 | |
CN110157589A (zh) | 一种鸭梨保健醋及其制备工艺 | |
CN108782771A (zh) | 一种罗汉果红枣杏仁露及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
CB02 | Change of applicant information | ||
CB02 | Change of applicant information |
Address after: 047100 Zhendong science and Technology Park, Guangming South Road, Shangdang District, Changzhi City, Shanxi Province Applicant after: Shanxi Zhendong Wuhe medical care hall Co.,Ltd. Address before: 047100 Zhendong science and Technology Park, Guangming South Road, Shangdang District, Changzhi City, Shanxi Province Applicant before: Shanxi Zhendong Wuhe Health Technology Co.,Ltd. |
|
RJ01 | Rejection of invention patent application after publication | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20210806 |